%D9%85%D8%AA%D9%84%D8%A7%D8%B2%D9%85%D8%A9_%D8%A3%D9%86%D8%AC%D9%84%D9%85%D8%A7%D9%86S%C3%ADndrome_d%27AngelmanCategory:Angelman_syndromeAngelman%C5%AFv_syndromAngelman-SyndromAngelman_syndromeS%C3%ADndrome_de_AngelmanAngelmani_s%C3%BCndroom%D8%B3%D9%86%D8%AF%D8%B1%D9%85_%D8%A2%D9%86%D8%AC%D9%84%D9%85%D9%86Angelmanin_oireyhtym%C3%A4Syndrome_d%27Angelman%D7%AA%D7%A1%D7%9E%D7%95%D7%A0%D7%AA_%D7%90%D7%A0%D7%92%D7%9C%D7%9E%D7%9FAngelmanov_sindromAngelman-szindr%C3%B3ma%D4%B1%D5%B6%D5%BB%D5%A5%D5%AC%D5%B4%D5%A1%D5%B6%D5%AB_%D5%B0%D5%A1%D5%B4%D5%A1%D5%AD%D5%BF%D5%A1%D5%B6%D5%AB%D5%B7Sindrome_di_Angelman%E3%82%A2%E3%83%B3%E3%82%B8%E3%82%A7%E3%83%AB%E3%83%9E%E3%83%B3%E7%97%87%E5%80%99%E7%BE%A4%EC%95%88%EC%A0%A4%EB%A7%8C_%EC%A6%9D%ED%9B%84%EA%B5%B0Syndroom_van_Angelman%E0%AC%86%E0%AC%9E%E0%AD%8D%E0%AC%9C%E0%AD%87%E0%AC%B2%E0%AC%AE%E0%AD%8D%E0%AD%9F%E0%AC%BE%E0%AC%A8_%E0%AC%B8%E0%AC%BF%E0%AC%A3%E0%AD%8D%E0%AC%A1%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%AEZesp%C3%B3%C5%82_AngelmanaS%C3%ADndrome_de_Angelman%D0%A1%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC_%D0%90%D0%BD%D0%B3%D0%B5%D0%BB%D1%8C%D0%BC%D0%B0%D0%BD%D0%B0Angelmanov_sindrom%D0%90%D0%BD%D0%B3%D0%B5%D0%BB%D0%BC%D0%B0%D0%BD%D0%BE%D0%B2_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BCAngelmans_syndrom%E0%AE%8F%E0%AE%9E%E0%AF%8D%E0%AE%9A%E0%AE%B2%E0%AF%8D%E0%AE%AE%E0%AE%A9%E0%AF%8D_%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8D%E0%AE%A4%E0%AF%8D%E0%AE%A4%E0%AF%8A%E0%AE%95%E0%AF%88%E0%B8%81%E0%B8%A5%E0%B8%B8%E0%B9%88%E0%B8%A1%E0%B8%AD%E0%B8%B2%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B9%81%E0%B8%AD%E0%B8%87%E0%B9%80%E0%B8%81%E0%B8%A5%E0%B9%81%E0%B8%A1%E0%B8%99Angelman_sendromu%D0%A1%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC_%D0%90%D0%BD%D0%B3%D0%B5%D0%BB%D1%8C%D0%BC%D0%B0%D0%BD%D0%B0H%E1%BB%99i_ch%E1%BB%A9ng_AngelmanQ535364%E1%83%90%E1%83%9C%E1%83%92%E1%83%94%E1%83%9A%E1%83%9B%E1%83%90%E1%83%9C%E1%83%98%E1%83%A8_%E1%83%A1%E1%83%98%E1%83%9C%E1%83%93%E1%83%A0%E1%83%9D%E1%83%9B%E1%83%98%E5%A4%A9%E4%BD%BF%E4%BA%BA%E7%97%87%E5%80%99%E7%BE%A4
about
Prader-Willi and Angelman SyndromeAngelman Syndrome Italian RegistryNutritional Formulation for Angelman SyndromeClinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man SyndromeMinocycline in the Treatment of Angelman SyndromeAn Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman SyndromeStudy to Evaluate the Efficacy and Safety of Minocycline in Angelman SyndromeSNP-based Microdeletion and Aneuploidy RegisTry (SMART)Study on Tolerability of Levodopa/Carbidopa in Children With Angelman SyndromeStudy on the Brain Network of Angelman SyndromeA Trial of Levodopa in Angelman SyndromeDietary Supplements for the Treatment of Angelman SyndromeSleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PWCharacterization of Angelman SyndromeSingle Dose Pharmacokinetic (PK) StudyStudy of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion SyndromesA Study in Adults and Adolescents With Angelman SyndromeA Study of OV101 in Individuals With Angelman Syndrome (AS)Angelman Syndrome (AS) Biomarker StudyA Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome
P1050
The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disordersThe role of MeCP2 in brain development and neurodevelopmental disordersUnderstanding the pathogenesis of Angelman syndrome through animal modelsEpilepsy in patients with Angelman syndrome.Unmet clinical needs and burden in Angelman syndrome: a review of the literature.Novel intragenic deletions within the UBE3A gene in two unrelated patients with Angelman syndrome: case report and review of the literature.Angelman Syndrome Italian RegistryNutritional Formulation for Angelman Syndrome
P921
Q44013803-12fa9fb6-4ac4-8b95-df29-06fa63f3a946Q62025411-18718178-55A6-4D80-B01A-EAD337B051FDQ62025884-5E401E99-F9E4-4959-82AE-29F019756003Q63011572-716E0743-52D3-4F10-B67A-820E06EF6AEBQ63316713-8C1E56A0-CD55-4D35-BD79-6C26E23568A0Q63582599-8B38953A-88C4-4C9E-AD14-1CD86D02E2F0Q64336234-FB34FC6F-7F76-49ED-9E54-687690A6BCB5Q64398222-ABF8A9DF-EFA7-4042-95CD-1C374DA119ECQ64693689-DA9A1429-05B5-48FD-8BB7-AB6F29B546B3Q64807758-4B40EB89-61AB-458C-8520-FAC6A3A8E0A8Q65375519-6F4BA06E-9723-41C3-9C1D-32ED806BC051Q65388338-30CE0311-C138-4A0E-B134-1E05342A3C65Q65403983-BE1D38B1-2674-4BC9-9576-18C29FA9EDD2Q65538025-9378C213-782F-423A-90EE-41991D030B44Q66047187-5675CF4F-E175-44BC-AB3D-012532D139BEQ66062034-2558FC5E-EBB2-4F41-8056-323D0411460BQ66392949-92A41710-68E0-441A-A552-D4246F4E33ABQ74279763-4C2764C0-326C-4A09-9518-82EE64017C3DQ74280963-FE298F40-77B8-4BA9-8250-1BA30326356DQ86312571-9C8B6EB7-1003-426E-90DC-5305886663E7
P1050
Q54750572-D0C2DDFB-0D66-4627-94B3-F6145B54AEA8Q54750575-ECD3F7F7-4134-42EC-91B9-59BBB3B3D778Q54750577-3C8BDF94-24B5-4C64-B1DB-F4456DF54476Q54750580-7D8D6867-D2CE-405E-86B4-6F2A805FED8EQ54797769-6BB17478-BA48-4AB6-B7E2-3BA2422DDBD2Q54828777-6A2EAFBC-699F-45B0-BBDE-B0F0C6772248Q54828834-DAC91496-977E-4DC3-AFAC-52C1D22249AAQ54845060-AB2ECD37-93BF-4D83-997E-C2BC3AA9E344Q54845129-3A7ED73D-ADEC-4455-8D68-3603F5AD15CDQ54845130-144687C4-04C8-43E2-94E5-187EFF79538FQ54847566-80CE1634-072C-45FD-ADA3-B15E3F2A8309Q54850986-1A7C907C-556A-4477-81AC-EA71C1C5EA71Q54851011-6E25B6BB-97BB-460F-AA28-6814B74D4C37Q54851012-96A21996-FA65-4D6E-83DE-07DF6E810722Q54851013-974A9FA3-F241-4A39-BD2B-6F8F1CB9747BQ54852209-A79C5784-DC5F-430A-A1B2-1A86B96168D7Q54853625-D8955733-7992-4574-B2F5-79B55C404A99Q54993908-3E284FC0-EA99-47FB-8034-64BE0BF1D617Q93453810-6490568D-85C1-44D6-A1EF-B2BFE763151AQ94219886-48F99215-A01B-428D-873D-C8A5DC65258DQ94219891-E0E4688F-08C8-4C38-BE0C-8D8A34B9C2B5Q94219896-D9CFD4D8-286F-4BC3-A499-3FDD4B8C72F5Q94219900-F09CEE36-69E4-4304-97C3-05835BCD1219Q94219905-F50F8B7D-9A36-4877-A481-5CA44DE47F0AQ94219909-E2ECD4BA-ED14-41EC-A271-88468A3BABE7Q94220204-79C26A49-3252-42DC-9627-5ABFFF2D5FEEQ94220209-5CA96320-2A44-4E8D-8105-EB75BCD393F5Q94220213-7B04FFA6-A8A5-46C3-BFDA-8165245942BEQ94220217-A3E7439E-2433-4D76-9EEF-6F6DED5DB6FAQ94220221-E9A21765-58FF-4603-98A1-A19969CBF62AQ94220226-6B7F209A-56C0-4B95-A87A-617D3833602F
P5166
description
Genetic condition in humans
@en
Krankheit
@de
genetycznie uwarunkowany zespół chorobowy
@pl
malattia genetica umana
@it
trouble sévère du développement neurologique dont l'origine est génétique
@fr
Ανθρώπινη νόσος
@el
مرض يصيب الإنسان
@ar
name
Angelman Sendromu
@tr
Angelman syndrome
@en
Angelman-Syndrom
@de
Angelman-szindróma
@hu
Angelmani sündroom
@et
Angelmanin oireyhtymä
@fi
Angelmanov sindrom
@hr
Angelmanov sindrom
@sh
Angelmans syndrom
@sv
Angelmanův syndrom
@cs
type
label
Angelman Sendromu
@tr
Angelman syndrome
@en
Angelman-Syndrom
@de
Angelman-szindróma
@hu
Angelmani sündroom
@et
Angelmanin oireyhtymä
@fi
Angelmanov sindrom
@hr
Angelmanov sindrom
@sh
Angelmans syndrom
@sv
Angelmanův syndrom
@cs
altLabel
AS
@en
Angelman Syndrome Chromosome Region
@en
Angelman Syndrome
@th
Angelman sendromu
@tr
Angelman syndrome
@he
Angelman syndrome
@th
Angelman syndroom
@nl
Angelman's syndrome
@th
Angelmanin syndrooma
@fi
Angelmanni sündroom
@et
prefLabel
Angelman Sendromu
@tr
Angelman syndrome
@en
Angelman-Syndrom
@de
Angelman-szindróma
@hu
Angelmani sündroom
@et
Angelmanin oireyhtymä
@fi
Angelmanov sindrom
@hr
Angelmanov sindrom
@sh
Angelmans syndrom
@sv
Angelmanův syndrom
@cs
P279
P2888
P2892
P31
P672
P227
P486
P508
P646
P1325
P138
P1417
topic/Angelman-syndrome